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ABSTRACT: Background. Recent evidence suggests that head and
neck squamous cell carcinomas (HNSCCs) harbor a small subpopulation
of highly tumorigenic cells, designated cancer stem cells. A limiting
factor in cancer stem cell research is the intrinsic difficulty of expanding
cells in an undifferentiated state in vitro.
Methods. Here, we describe the development of the orosphere assay,
a method for the study of putative head and neck cancer stem
cells. An orosphere is defined as a nonadherent colony of cells
sorted from primary HNSCCs or from HNSCC cell lines and cultured
in 3-dimensional soft agar or ultralow attachment plates. Aldehyde
dehydrogenase activity and CD44 expression were used here as
stem cell markers.
Results. This assay allowed for the propagation of head and neck cancer
cells that retained stemness and self-renewal.
Conclusion. The orosphere assay is well suited for studies designed to
understand the pathobiology of head and neck cancer stem cells.
VC 2012 Wiley Periodicals, Inc. Head Neck 35: 1015–1021, 2013
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INTRODUCTION
The cancer stem cell hypothesis provides a plausible
mechanism for tumor recurrence and metastatic spread.1
According to the cancer stem cell hypothesis, a small sub-
population of cancer cells is highly tumorigenic and is ca-
pable of self-renewal and multipotency.2 Cells with such
features may constitute the "drivers’’ of the tumorigenic
process.2 If this hypothesis were indeed true for head and
neck squamous cell carcinomas (HNSCCs), selective tar-
geting of these cancer stem cells would be essential to
improve patient outcomes. Following the discovery of
cancer stem cells in HNSCC,3 investigators throughout
the world have begun studies to understand the pathobiol-
ogy of these cells. The development and optimization of
a method for in vitro expansion of head and neck cancer
stem cells in an undifferentiated state would be beneficial
for the progress of research in this area, and hopefully
will accelerate the process of developing improved treat-
ment modalities for HNSCCs.
Two cardinal properties of stem cells allow for their
identification and purification: (1) self-renewal, that is,
the ability of stem cells to self-perpetuate, and (2) multi-
potency, that is, the ability of cells to undergo differentia-
tion and generate the complex cellular components
observed in a tissue/organ or in cancer.4–6 It is possible to
maintain human head and neck cancer stem cells in an
undifferentiated state by serially passaging them in vivo,
in immunodeficient mice.7 However, this strategy is time-
consuming and expensive. Furthermore, it is difficult to
perform mechanistic studies of signaling pathways
involved in the biology of cancer stem cells exclusively
in animal models. A third property of stem cells, that is,
the ability to form spheres and grow under low attach-
ment conditions,8,9 inspired the development of in vitro
assays for the study of normal and cancer stem cells.
Exploiting the fact that stem cells possess anchorage in-
dependence, that is, the ability to survive and proliferate
in suspension cultures unlike the nonstem cells,8,9 adher-
ent-free culture conditions have been proposed as the
basis for in vitro assays for propagation of cancer stem
cells. Suspension cultures have been used as a method to
study stem cell properties in several tumor types, includ-
ing those of the breast and brain.10,11 Most of these sus-
pension cultures are done in 3-dimensional (3D) struc-
tures, such as soft agar matrices or dishes coated with
fibronectin or matrigel.12–14 These strategies allow for
stem cell expansion and proliferation, making them a val-
uable assay for self-renewal. However, the setup of these
cultures is technically challenging, and the intrinsic diffi-
culty associated with the retrieval of the cells from their
matrix makes this method not ideal when mechanistic
studies involving serial passaging, flow cytometry, or
gene-expression analyses are required. In an attempt to
address such issues, the culture of cells in low-attachment
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plates has been proposed as an alternative strategy to
deprive cells from anchorage, while facilitating their re-
trieval of cells for further analysis.15–17
Fluorescence-activated cell sorting (FACS) and mag-
netic bead sorting are common approaches for the identi-
fication and isolation of putative stem cells.18,19 Using
FACS, we observed that the fraction of putative cancer
stem cells in primary HNSCC is small.7 Here, we
describe a method for the propagation of head and neck
cancer stem cells: the orosphere assay. The designation
reflects the fact that this method was optimized for stud-
ies of stem cells sorted from tumors or cell lines derived
from the oral cavity and head and neck region. This
method enables the expansion of cancer stem cells in an
undifferentiated state by culturing them in ultralow
attachment plates or in 3D soft agar matrices. The use of
ultralow attachment plates allowed for serial passaging of
cells (ie, demonstration of self-renewal), and for the re-
trieval of cells for mechanistic studies.
MATERIALS AND METHODS
Sorting and culture of head and neck cancer stem cells
HNSCC cells (UM-SCC-74A, UM-SCC-74B; gift
from Dr. Carey, University of Michigan) were cultured
in Dulbecco’s modified Eagle’s medium (DMEM; Invi-
trogen; Grand Island, NY), 10% fetal bovine serum, 100
U/mL penicillin, and 100 lg/mL streptomycin. The
identity of the tumor cell lines was confirmed by geno-
typing at the University of Michigan DNA sequencing
core facility. Alternatively, putative cancer stem cells
were isolated from primary tumors, as described.7
Briefly, informed consent was obtained from 2 patients
prior to surgical removal of HNSCC under a protocol
approved by the University of Michigan Institutional
Review Board (IRB). The information about the tumor
site and patient demographics is described in Supple-
mentary Table S1. The specimens were cut into small
pieces, minced until they passed through a 25-mL pip-
ette tip, and suspended in a 9:1 solution of DMEM-F12
(Hyclone, Waltham, MA) containing collagenase and
hyaluronidase (Stem Cell Technologies, Vancouver, BC,
Canada). The mixture was incubated at 37C for 1 hour
and passed through a 10-mL pipette every 15 minutes
for mechanical dissociation. Cells were filtered through
a 40-lm nylon mesh (BD Falcon, Franklin Lakes, NJ),
washed with low glucose DMEM (Invitrogen) contain-
ing 10% FBS, and centrifuged at 800 rpm for 5 minutes.
Single-cell suspensions obtained from primary speci-
mens (as well as from HNSCC cell lines) were washed,
counted, and resuspended at 106 cells/mL PBS. The
Aldefluor kit (Stem Cell Technologies) was used to
identify cells with high aldehyde dehydrogenase
(ALDH) activity. Briefly, cells were suspended in acti-
vated Aldefluor substrate (BAA) or in DEAB (specific
ALDH inhibitor) for 45 minutes at 37C. Then, cells
were exposed to anti-CD44 antibody (clone G44–26BD;
BD Pharmingen, Franklin Lakes, NJ) and lineage (Lin)
markers (ie, anti-CD2, CD3, CD10, CD16, CD18; BD
Pharmingen). Viable cells are identified with 7-aminoac-
tinomycin (7-AAD; BD Pharmingen). FACS-sorted cells
were cultured in low glucose DMEM (Invitrogen), 10%
fetal bovine serum, and 100 U/mL penicillin–streptomy-
cin in low-attachment conditions, as described in the fol-
lowing text. Cells were defined as putative head and
neck cancer stem cells (ALDHþCD44þLin–) or control
cells (ALDH–CD44–Lin–). To induce cell differentia-
tion, FACS-sorted cells were cultured in regular tissue
culture plates (BD Falcon). All studies were done in
triplicate wells per condition. Experiments with cell
lines were performed at least 3 independent times to
verify reproducibility of the data and experiments with
cells retrieved from primary HNSCC were performed
twice independently.
Orospheres in ultralow attachment plates
FACS-sorted cells (5  103 cells/well) were seeded in
6-well ultralow attachment plates (Corning, New York,
NY) and cultured in low-glucose DMEM, 10% fetal bo-
vine serum, and 100 U/mL penicillin–streptomycin at
37C and 5% CO2. Orospheres were arbitrarily defined as
a nonadherent colony of at least 25 cells. Orospheres can
be mechanically dissociated into single-cell suspensions
and then reseeded in new ultralow attachment plates to
generate secondary and tertiary orospheres (indicative of
self-renewal).
Orospheres in soft agar
Alternatively, orospheres can be generated using low melt-
ing point agarose (Invitrogen). Six-well regular attachment
plates (Fisher) were precoated with a layer of 1.2% agarose
mixed with an equal volume of 2 DMEM (Invitrogen) to
make an inert basal layer. This layer is solidified at room
temperature for 45 minutes. Then, 500 FACS-sorted cells/
well were resuspended in 2 DMEM (Invitrogen) mixed
with equal volumes of 0.6% agarose. After the second aga-
rose layer gelified at room temperature for 30 minutes, 500
lL low-glucose DMEM (Invitrogen) was added onto the
surface of the 3D matrix and cells were incubated at 37C
thereafter. Usually the orospheres in soft agar were visual-
ized after 7 days. Quantification of the number of oro-
spheres/well was done under light microscopy.
Immunocytochemistry
For immunocytochemistry, 2  103 FACS-sorted cells/
well were cultured in LabTek II Chamber Slide (Thermo
Scientific, Rochester, NY) or in ultralow attachment
plates for up to 7 days. Antigen retrieval was performed
using Dako Retrieval solution (S1699; Carpinteria, CA)
with gradual warming up from 40 to 98C within 40
minutes. Slides were incubated in 3% hydrogen peroxi-
dase for 10 minutes. Primary antibodies against Cytokera-
tin 17 (1:200; Abcam, ab2502; San Francisco, CA) or
Involucrin (1:200; Abcam ab27496) were incubated at
4C overnight. Following a 20-minute incubation with
appropriate secondary antibodies, the Romulin AEC
Chromogen Kit (Biocare Medical, Concord, CA) was
used to visualize the proteins.
Immunofluorescence and confocal imaging
For confocal imaging, 2  103 FACS-sorted cells/well
were seeded in a 24-well ultralow attachment plate
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(Corning). Orospheres were fixed in cold 10% buffered
formalin (Fisher, Pittsburgh, PA) for 30 minutes. For im-
munofluorescence, primary antibodies were prelabeled
with Alexafluor 488 or 594 using a Zenon labeling kit
(Molecular Probes, Z25007, Z25102; Invitrogen). Primary
antibodies, that is, anti-ALDH1 (1:50; BD Biosciences,
61195; Franklin Lakes, NJ); CD44 (1:200; Abcam,
ab51037) were added directly to the plate and incubated
at 4C overnight. Orospheres were transferred to LabTek
II Chambered Coverglass (Thermo Scientific) and
mounted with Prolong Gold antifade mounting medium
with DAPI (Invitrogen). Confocal imaging was performed
using Leica Inverted Confocal SP5X (Leica, Los Angeles,
CA). Postprocessing was done with NIH ImageJ software.
Statistical analyses
One-way analysis of variance (ANOVA) followed by
appropriate post hoc tests was performed using the Sig-
maStat 2.0 software (SPSS, Chicago, IL). Statistical sig-
nificance was determined at p < .05.
RESULTS
We have recently shown that ALDHþCD44þLin– cells
sorted from primary HNSCC exhibit self-renewal and are
more tumorigenic than control ALDH–CD44–Lin– cells.7
Such features characterize the ALDHþCD44þLin– cells
as putative head and neck cancer stem cells. Here, we
describe the characterization and optimization of a method
that was developed to propagate and to evaluate the stem
cell properties of cells derived from primary head and
neck tumors or from HNSCC cell lines. Single-cell suspen-
sions were prepared from freshly dissected human HNSCC
or from HNSCC cell lines. Cells were sorted for high/low
ALDH activity (Aldefluor kit) and CD44 expression. A
representative flow sorting of the head and neck cancer
stem cells from a primary human HNSCC (HN 03) is
shown in Figure 1A, wherein the percentage of lineage-
negative viable ALDHþCD44þLin– is 0.97%, whereas
the percentage of lineage-negative viable noncancer stem
cells (ALDH–CD44–Lin–) is 3.09%. The percentage of
ALDHþCD44þLin– and ALDH–CD44–Lin– cells was
calculated using as reference the total number of viable
cells in the specimen. After flow sorting, cells were cul-
tured under low-attachment conditions to form nonadherent
spheres designated orospheres. To generate these oro-
spheres, we optimized conditions for HNSCC cells cul-
tured either in ultralow attachment plates or in soft agar
3D matrices. Although orospheres can be readily seen
within 3 days in ultralow attachment plates, it takes
FIGURE 1. In vitro propagation of putative head and neck cancer stem cells in orospheres. (A) Representative flow cytometry sorting of putative
cancer stem cells from a primary human head and neck squamous cell carcinoma. Shortly after surgery, single-cell suspensions were prepared by
digestion of the tumor specimen with collagenase and hyaluronidase. Viable cells (P1) were isolated using 7AAD and are gated for positivity (after
eliminating lineage cells) to ALDH (P5), using DEAB (ALDH inhibitor) as reference. ALDH-negative cells are found in P6. The cells were then gated
against CD44 in sequence to select ALDHþCD44þLin- (P7 ¼ 0.97%) and ALDH-CD44-Lin- (P8 ¼ 3.09%). (B, C) Representative photomicrographs
of orospheres arising from ALDHþCD44þLin– and ALDH–CD44–Lin– cells sorted from a primary HNSCC (B) or from a HNSCC cell line, that is, UM-
SCC-74A (C). Cells were cultured either in ultralow attachment plates or in 3D soft agar matrices.
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approximately 7 days to generate orospheres in soft agar
(Figures 1B, 1C). Notably, the orospheres shown here
were generated either from cells sorted from one primary
human HNSCC (Figure 1B) or from a head and neck can-
cer cell line, that is, UM-SCC-74A (Figure 1C).
To begin to understand the biology of the cells forming
the orospheres, we cultured them for 3 days in ultralow
attachment plates and visualized the expression of the 2
stem cell markers used to sort the cells initially (ALDH1
and CD44) by confocal microscopy (Figure 2A). To
determine if the culture of putative cancer stem cells in
low attachment represents a self-renewal method resulting
in stem cell expansion, and not just an aggregation of
stem-like cells, we seeded a single ALDHþCD44þ cell/
well in 96-well ultralow attachment plate and monitored
its clonal expansion for 5 days (Figure 2B). We observed
that a higher number of individual clones were formed by
the putative cancer stem cells (ALDHþCD44þ) when
compared with control ALDH–CD44– cells (*p < .05, n
¼ 3). A clone was defined as a colony of at least 10
cells, starting from a single cell.
To evaluate if the orosphere assay is a valid method
for testing self-renewal of head and neck cancer stem
cells, we cultured orospheres generated from
ALDHþCD44þ cells or control cells for 3 days under
ultralow attachment conditions. Then, the orospheres
were mechanically dissociated and reseeded as single-cell
suspension in new ultralow attachment plates. This pro-
cess was repeated serially to generate secondary and terti-
ary orospheres (Figure 2C). This experiment revealed 2
general trends: (1) more orospheres were generated from
the ALDHþCD44þ than from the control cells over
time, demonstrating the self-renewal of the putative can-
cer stem cells; and (2) a progressive decrease in the over-
all number of orospheres was observed between the pri-
mary and the tertiary passages.
We wanted to ascertain that suspension culture in low-
attachment plates was the reason for the continued
enrichment of cancer stem cells, and that ALDHþCD44þ
cells do retain their stemness over time. We therefore cul-
tured ALDHþCD44þ cells in regular attachment condi-
tions or in ultralow attachment plates. FACS analysis
revealed the maintenance of a higher percentage of
ALDHþCD44þ cells when culturing in ultralow attach-
ment conditions as compared with regular attachment
plates (Figure 2D; Supplementary Figure S1). The reverse
experiment was performed to evaluate if the same puta-
tive head and neck cancer stem cells (ALDHþCD44þ)
would lose their stemness and differentiate when cultured
in regular attachment plates. This analysis was performed
by immunostaining for Cytokeratin 17 (an epithelial stem
cell marker) and Involucrin (a differentiated cell
marker).20,21 We observed that on day 0, the ALDHþ
CD44þ cells were more spherical and expressed high
FIGURE 2. Characterization of stem cell properties of orospheres. (A) Confocal microscopy of an orosphere generated from the UM-SCC-74B cell
line and stained for the stem cell markers ALDH1 (green) and CD44 (red), along with nuclei staining with DAPI (blue). (B) Graph depicting the
number of clones arising from one individual cancer stem cell (ALDHþCD44þ) or noncancer stem cell (ALDH–CD44–) per well of a 96-well
ultralow attachment plate. (C) Graph depicting the number of orospheres generated from serial passage assays that evaluate self-renewal of
putative cancer stem cells (ALDHþCD44þ) or control cells (ALDH–CD44–). (D) Graph depicting the percentage of ALDHþCD44þ cells (FACS) over
time when cultured in regular attachment or ultralow attachment conditions (n ¼ 3). Asterisk depicts p < .05, when data are analyzed against
controls within same time point.
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levels of Cytokeratin 17 and low levels of Involucrin
(Figures 3A, 3B). By day 7, the ALDHþCD44þ cells
became more elongated and reversed the expression lev-
els of Cytokeratin 17 and Involucrin.
To further evaluate the impact of culture conditions on
the stemness of ALDHþCD44þ cells over time, we cul-
tured ALDHþCD44þ cells in regular or ultralow attach-
ment conditions and evaluated ALDH1 expression by
Western blots. We observed that ALDH1 was not
expressed in cells that were cultured under regular attach-
ment conditions at day 3, and thereafter (Supplementary
Figure S2). In marked contrast, expression of ALDH1
was maintained at the same level as baseline at 3 days,
and somewhat decreased, but still clearly present, in cells
cultured in ultralow attachment conditions after 7 days.
Oral keratinocytes, that is, fully differentiated cells, were
used as controls for this experiment.
DISCUSSION
The orosphere assay is conceptually derived from sus-
pension cultures developed to study normal or cancer
stem cells from tissues such as the brain, breast, or pros-
tate.9,10,22,23 Pioneer work from Reynolds and Weiss dem-
onstrated that cells dissected from the striatum of the
adult mouse brain could be cultured as free-floating
spheres and exhibited stem cell properties.9,22 The Wicha
laboratory characterized human mammary stem/progenitor
cells from reduction mammoplasties based on their an-
chorage independence and survival in low-attachment
plates.10 These seminal findings provided the conceptual
framework for the development of sphere-based assays as
a means to propagate cancer stem cells in an undifferenti-
ated state in vitro. Here, we describe a method in which
putative cancer stem cells are sorted from heterogeneous
HNSCC primary tumors or from established HNSCC cell
lines. These putative cancer stem cells differentiate under
regular attachment conditions and generate heterogeneous
tumor cell monolayers within a few days. On the other
hand, the same cells cultured in low-attachment condi-
tions are capable of retaining stem-like cell properties
(see Figure 4). Notably, the method described here is
clearly inspired by the existing protocols from other tu-
mor types, but was optimized for use in head and neck
tumor models.
One of the critical challenges facing stem cell studies is
the definition of markers that discriminate highly tumori-
genic cells (cancer stem cells) from cells that possess low
tumorigenic potential. Mounting evidence suggests that
stem cell markers are tumor-specific, and that CD44,
CD133, and ALDH are emerging as useful markers in
HNSCC. Seminal work from the Prince laboratory used
CD44 expression as a marker for the identification of a
subpopulation of highly tumorigenic stem cells in primary
HNSCC.3 More recently, it was shown that CD44þ cells
sorted from an HNSCC cell line cultured in uncoated
dishes formed tumor spheres that were resistant to chemo-
therapeutic drugs.24 CD133, a transmembrane glycopro-
tein, is considered a putative marker for cancer stem cells
in head and neck tumors. CD133-positive cells sorted
from HNSCC cell lines or primary tumors showed
enhanced clonality and tumorigenicity when compared
FIGURE 3. Characterization of the differentiation of ALDHþCD44þ cells cultured in regular attachment plates. (A) Representative
photomicrographs of Cytokeratin 17 and Involucrin immunostaining of ALDHþCD44þ cells cultured under regular attachment conditions for 1
week. (B) Graph depicting the percentage of cells cultured in regular attachment plates and that stained positive for Cytokeratin 17 or Involucrin
over time. Asterisk depicts p < .05, when data are analyzed against baseline (day 0).
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with control cells.25–27 Alternatively, ALDH activity,
which was initially characterized as a useful stem cell
marker in breast cancer,28 was also validated in head and
neck tumor models.29,30 Of note, since most markers are
expressed in both normal and pathologic stem cells, it is
plausible that the combination of markers may enhance
one’s ability to identify cancer stem cells from complex
primary tumor tissues. Indeed, it has been recently
observed that the combination of ALDH activity and
CD44 expression further discriminates a small subpopula-
tion (<3%) of cells in primary HNSCC that exhibit stem-
like properties and are highly tumorigenic.7
As with most methods, the orosphere assay has its in-
herent limitations, as follows: (1) the overall number of
orospheres decreases upon serial passaging; and (2) the
percentage of ALDHþCD44þ cells is higher in ultralow
attachment plates than in regular culture plates, but it
decreases over time. Collectively, these findings suggest
that there might be a certain degree of cell differentiation
even in low-attachment conditions in vitro. Although
these limitations can be overcome by expanding cancer
stem cells in vivo,3,7 such a strategy makes the process of
propagating cells in an undifferentiated state labor and
animal intensive, and expensive. Although the "oro-
sphere’’ assay has the advantages of being technically
simple, reproducible, and relatively inexpensive, one
must remain mindful of the limitations of the assay and
interpret the data with caution. Therefore, the orosphere
assay should be used in combination with appropriate ani-
mal models.
We described here the protocols for generating oro-
spheres in either soft agar 3D matrices or in ultralow
attachment plates. Careful consideration should be given
to the advantages and disadvantages of each method,
before selecting the best approach for a specific experi-
mental question. The soft agar method is more time con-
suming. One has to precoat the plate with a layer of aga-
rose, wait for its gelification, apply a second layer
containing both agarose and cells, wait again, and finally
cover the 3D gel with culture medium. Along the same
lines, it takes about 7 days to generate orospheres in soft
agar, whereas it takes only 3 days in ultralow attachment
plates. In addition, the soft agar approach does not allow
for retrieval of the cells for mechanistic studies (eg, flow
cytometry, gene-expression analyses) or for serial passage
studies (eg, to evaluate self-renewal properties). As a
potential advantage though, the soft agar assay tends to
be a more rigorous testing of stem cell properties. We
observed that noncancer stem cells do not survive well
under these conditions and do not readily form oro-
spheres. On the other hand, the culture of undifferentiated
cells in ultralow attachment plates is simpler, since there
is no need for coating and gelification steps. This culture
condition is highly suitable for the retrieval of cells for
serial passage or for mechanistic studies. Knowing the
pros and cons of both strategies should direct the decision
process toward selecting the soft agar or the ultralow
attachment approach.
The field of cancer stem cell biology has attracted
much attention in recent years due to the discovery that
FIGURE 4. Diagram illustrating the in vitro propagation of putative head and neck cancer stem cells using the orosphere assay. Single-cell
suspensions are prepared from head and neck squamous cell carcinomas and sorted for stem cell markers, such as ALDH and CD44. The putative
cancer stem cells can be serially passaged and expanded in ultralow attachment conditions using the orosphere assay. Alternatively, these cells
can be differentiated when cultured in regular attachment conditions generating a heterogeneous cancer cell line.
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these cells may drive the progression of certain tumor
types, including HNSCC. As such, the emergence of tar-
geted therapy against cancer stem cells could have a sig-
nificant impact on the survival of patients with head and
neck cancer. The authors believe that the development
and characterization of methods to propagate and study
the behavior of cancer stem cells in vitro may ultimately
contribute to the discovery of mechanism-based therapies
for HNSCC.
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